- Home
- GRVY vs AURA Comparison
GRVY vs AURA Comparison
Compare GRVY & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRVY
- AURA
- Stock Information
- Founded
- GRVY 2000
- AURA 2007
- Country
- GRVY South Korea
- AURA United States
- Employees
- GRVY N/A
- AURA N/A
- Industry
- GRVY Business Services
- AURA Biotechnology: Pharmaceutical Preparations
- Sector
- GRVY Consumer Discretionary
- AURA Health Care
- Exchange
- GRVY Nasdaq
- AURA Nasdaq
- Market Cap
- GRVY 421.6M
- AURA 370.1M
- IPO Year
- GRVY 2005
- AURA 2021
- Fundamental
- Price
- GRVY $63.39
- AURA $6.10
- Analyst Decision
- GRVY
- AURA Strong Buy
- Analyst Count
- GRVY 0
- AURA 5
- Target Price
- GRVY N/A
- AURA $22.60
- AVG Volume (30 Days)
- GRVY 12.0K
- AURA 248.2K
- Earning Date
- GRVY 05-09-2025
- AURA 05-15-2025
- Dividend Yield
- GRVY N/A
- AURA N/A
- EPS Growth
- GRVY N/A
- AURA N/A
- EPS
- GRVY 7.83
- AURA N/A
- Revenue
- GRVY $339,753,162.00
- AURA N/A
- Revenue This Year
- GRVY N/A
- AURA N/A
- Revenue Next Year
- GRVY N/A
- AURA N/A
- P/E Ratio
- GRVY $8.19
- AURA N/A
- Revenue Growth
- GRVY N/A
- AURA N/A
- 52 Week Low
- GRVY $53.12
- AURA $4.35
- 52 Week High
- GRVY $88.85
- AURA $12.38
- Technical
- Relative Strength Index (RSI)
- GRVY 49.77
- AURA 54.34
- Support Level
- GRVY $63.45
- AURA $5.68
- Resistance Level
- GRVY $66.14
- AURA $6.50
- Average True Range (ATR)
- GRVY 1.63
- AURA 0.42
- MACD
- GRVY -0.34
- AURA 0.05
- Stochastic Oscillator
- GRVY 14.57
- AURA 71.33
About GRVY GRAVITY Co. Ltd. American Depository Shares
GRAVITY Co Ltd is an online and mobile games developer and publisher based in Korea. Its principal product, Ragnarok Online, is an online game which is available in more than 91 markets. Its games include Ragnarok Online, Requiem, Dragonica (Dragon Saga), Ragnarok Online II, Requiem Online, and R.O.S.E. Online. The company generates revenue from online games, mobile games and other sources including character based merchandise and animation.
About AURA Aura Biosciences Inc.
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its lead candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.